All NewsPractice Management
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutWhat’s Your WhEYE?
Conference CoverageConference ListingConference Recaps
Blog
Digital EditionSupplements And Featured PublicationsiTech
Partners
Job BoardSponsored
SubscribeCE
AMD
Allergy
Blepharitis
COVID-19
Cataract
Comanagement
Comprehensive Eye Exams
Conjunctivitis
Contact Lenses
Cornea
DME
Diabetic Eye Disease
Dry Eye
Geographic Atrophy
Glasses
Glaucoma
LASIK
Lens Technology
Lid and Lash
Myopia
Nutrition
OCT
Ocular Surface Disease
Optic Relief
Patient Care
Pediatrics
Presbyopia
Ptosis
Refractive Surgery
Retina
Technology
Therapeutic Cataract & Refractive
Spotlight -
  • Geographic Atrophy
  • Myopia
EyeCare Network
  • Ophthalmology Times

  • Modern Retina

  • Optometry Times

  • Ophthalmology Times Europe

AMD
Allergy
Blepharitis
COVID-19
Cataract
Comanagement
Comprehensive Eye Exams
Conjunctivitis
Contact Lenses
Cornea
DME
Diabetic Eye Disease
Dry Eye
Geographic Atrophy
Glasses
Glaucoma
LASIK
Lens Technology
Lid and Lash
Myopia
Nutrition
OCT
Ocular Surface Disease
Optic Relief
Patient Care
Pediatrics
Presbyopia
Ptosis
Refractive Surgery
Retina
Technology
Therapeutic Cataract & Refractive
EyeCare Network
  • Ophthalmology Times

  • Modern Retina

  • Optometry Times

  • Ophthalmology Times Europe

    • Blog
    • Partners
    • Subscribe
    • CE
Advertisement

The consequences of dry eye: Increased incidence of psychiatric disorders, fibromyalgia and chronic fatigue following diagnosis

October 25, 2024
By Lynda Charters
News
Article

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes, investigators reported at the 2024 American Academy of Ophthalmology meeting.

Reviewed by Gavin Li, MS.

man experiences chronic fatigue following dry eye diagnosis - Image credit: Adobe Stock/©Prostock-studio

Image credit: Adobe Stock/©Prostock-studio

The consequences of dry eye can extend well past the physical limits of the eyeball, according to Gavin Li, MS. Dry eye significantly increases the risk of developing depression, anxiety, fibromyalgia and chronic fatigue, suggesting that dry eye may serve as an early indicator or cause of psychological distress, he reported. Mr Li, from the Icahn School of Medicine at Mount Sinai, New York, presented the findings of his group1 at the 2024 American Academy of Ophthalmology annual meeting in Chicago.

Although the link between dry eye and psychiatric conditions is well-documented, no longitudinal studies have explored the direction of this relationship. To address this gap in the literature, Mr Li and his colleagues assessed whether a new diagnosis of dry eye increases the risk of developing depression, anxiety, fibromyalgia and chronic fatigue compared to those without dry eye.

They used a US-wide Medicare sample to identify individuals who did not have a history of dry eye, fibromyalgia, chronic fatigue or a psychiatric diagnosis. Individuals who developed dry eye from 2012 to 2015 were identified and matched with a control group without dry eye by age, sex, and race, Mr Li recounted.

Dry eye increases susceptibility to psychiatric disorders and chronic pain syndromes

The authors identified 18,807 individuals without dry eye and 4,702 with dry eye.

The analysis showed that individuals with dry eye were 1.65 times more likely to develop depression, 1.62 times more likely to develop anxiety, 2.41 times more likely to develop fibromyalgia and 1.5 times more likely to develop chronic fatigue (P < 0.001, P < 0.001, P < 0.001, and P = 0.02, respectively).

The investigators point to aspects of previous studies that support their findings, including a strong negative association between dry eye severity and both quality of life and mental health survey scores.2,3

“Dry eye may be an early indicator or contributing factor to psychological distress, and patients who score above a certain threshold on dry eye surveys, such as the Ocular Surface Disease Index, may benefit from screening for psychiatric comorbidities,” they stated.

References

  1. Li G, Schneider YH, Klawe J, et al. Incidence of Psychiatric Disorders, Fibromyalgia and Chronic Fatigue Following Dry Eye Diagnosis Among Medicare Beneficiaries. Presented at the 2024 American Academy of Ophthalmology annual meeting, Chicago, October 18-21; Session: Cornea-External Diseases – PO272
  2. Ren Y, Tian J, Shi W, et al. Evaluation and correlation analysis of ocular surface disorders and quality of life in autoimmune rheumatic diseases: a cross-sectional study. BMC Ophthalmol. 2023;23:229. doi:10.1186/s12886-023-02959-5
  3. Sayegh RR, Yu Y, Farrar JT, et al. Ocular discomfort and quality of life among patients in the Dry Eye Assessment and Management Study. Cornea. 2021;40:869-876. doi:10.1097/ICO.0000000000002580

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
What's on the clinical wishlist for dry eye with Dr Bridgitte Shen Lee
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
ARVO 2025: The early adoption and utilization of perfluorohexoloctane (Miebo)
Steven Greenstein, MD, one of the cochairs of the Collaborative Care Symposium gave some insight into the upcoming conference and what attendees can expect.
A sneak peek into the Collaborative Care Symposium 2025 with Steven Greenstein, MD
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
ARVO 2025: Dr Julie Poteet reviews patient-reported outcomes following use of Blink Triple Care
Karl Stonecipher ASCRS 2025
Q&A with Karl Stonecipher, MD, on outcomes of LASIK using the Teneo platform to correct high myopia
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Predicting presbyopia reading ADD and progression with AI and machine learning algorithm
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
CIME 2025: What you missed in presbyopia tips, tricks, and updates
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
ARVO 2025: Rethinking centile growth curves in myopia management with Mark Bullimore, MCOptom, PhD
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
CIME 2025: Luke Lindsell, OD, MD, on bridging innovation and practical care in retinal disease
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
CIME 2025: How Neda Shamie, MD, optimizes cataract and refractive surgery comanagement
Related Content
Advertisement
Closeup of dry eye before and after treatment. Image credit: AdobeStock/AlessandroGrandini

Iolyx Therapeutics releases phase 2 results for ILYX-002 in autoimmune-associated dry eye disease

Martin David Harp, Editor, Ophthalmology Times
May 29th 2025
Article
Split image of dry eye before and after treatment Image credit: ©Alessandro Grandini - adobe.stock.com

Optometrists, organizations provide insight for State of Dry Eye survey

Jordana Joy, Associate Editor;Jessilin Quint, OD, MBA, MS, FAAO;Grace Koennecke
August 16th 2024
Podcast
Collaborative Care Symposium cochairs Gelles and Greenstein preview the 2025 meeting

Bridging disciplines and elevating care: A Q&A with John Gelles, OD, and Steven Greenstein, MD

John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA;Steven A. Greenstein, MD;Emily Kaiser Maharjan, Assistant Managing Editor
May 28th 2025
Article
VEW 2022: Guess again, your child is NOT too young for contact lenses

VEW 2022: Guess again, your child is NOT too young for contact lenses

Vittorio Mena, OD, MS,;Kassi Filkins, Editor
September 15th 2022
Podcast
Doctor administering glucose level test Image credit: AdobeStock/interstid

Hypoglycemia may promote a breakdown of the blood-retinal barrier, study finds

Kassi Filkins, Editor
May 22nd 2025
Article
Eye drop dispenser Image credit: AdobeStock/frankenphoto

US FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED

Jordana Joy, Associate Editor
May 21st 2025
Article
Related Content
Conference
|
Dry Eye
Advertisement
Closeup of dry eye before and after treatment. Image credit: AdobeStock/AlessandroGrandini

Iolyx Therapeutics releases phase 2 results for ILYX-002 in autoimmune-associated dry eye disease

Martin David Harp, Editor, Ophthalmology Times
May 29th 2025
Article
Split image of dry eye before and after treatment Image credit: ©Alessandro Grandini - adobe.stock.com

Optometrists, organizations provide insight for State of Dry Eye survey

Jordana Joy, Associate Editor;Jessilin Quint, OD, MBA, MS, FAAO;Grace Koennecke
August 16th 2024
Podcast
Collaborative Care Symposium cochairs Gelles and Greenstein preview the 2025 meeting

Bridging disciplines and elevating care: A Q&A with John Gelles, OD, and Steven Greenstein, MD

John D. Gelles, OD, FAAO, FIAOMC, FCLSA, FSLS, FBCLA;Steven A. Greenstein, MD;Emily Kaiser Maharjan, Assistant Managing Editor
May 28th 2025
Article
VEW 2022: Guess again, your child is NOT too young for contact lenses

VEW 2022: Guess again, your child is NOT too young for contact lenses

Vittorio Mena, OD, MS,;Kassi Filkins, Editor
September 15th 2022
Podcast
Doctor administering glucose level test Image credit: AdobeStock/interstid

Hypoglycemia may promote a breakdown of the blood-retinal barrier, study finds

Kassi Filkins, Editor
May 22nd 2025
Article
Eye drop dispenser Image credit: AdobeStock/frankenphoto

US FDA clears Grifols' Investigational New Drug application for immunoglobulin drops for the treatment of DED

Jordana Joy, Associate Editor
May 21st 2025
Article
Advertisement
Recent Content
Swept source anterior segment OCT aids in early diagnosis of childhood glaucoma. - Image credit: ©Serhii—stock.adobe.com

Swept-source anterior segment-OCT aids in early diagnosis of childhood glaucoma

Four hands putting together puzzle pieces Image credit: AdobeStock/Johnstocker

Pangaea Data and Topcon Healthcare announce strategic investment

Closeup of dry eye before and after treatment. Image credit: AdobeStock/AlessandroGrandini

Iolyx Therapeutics releases phase 2 results for ILYX-002 in autoimmune-associated dry eye disease

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease

FDA approves Alcon’s Tryptyr (AR-15512) for signs and symptoms of dry eye disease

View More Recent Content
Advertisement
Advertisement
x
Advertise
About Us
Editorial
Contact Us
Job Board
Terms & Conditions
Privacy
Do not sell my Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.